Overview

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This is a pilot study looking at using stereotactic radiosurgery and full dose chemotherapy to treat stage II and III lung cancer that is not amendable to surgical resection.
Phase:
Early Phase 1
Details
Lead Sponsor:
The Cooper Health System
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Cisplatin
Docetaxel
Paclitaxel
Pemetrexed